Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule
Moufida Ben Nasr,Vera Usuelli,Sergio Dellepiane,Andy Joe Seelam,Teresa Vanessa Fiorentino,Francesca D'Addio,Emma Fiorina,Cong Xu,Yanan Xie,Hari Baskar Balasubramanian,Eduardo Castillo-Leon,Lara Loreggian,Anna Maestroni,Emma Assi,Cristian Loretelli,Ahmed Abdelsalam,Basset El Essawy,Silvia Uccella,Ida Pastore,Maria Elena Lunati,Gianmarco Sabiu,Adriana Petrazzuolo,Giacomo Ducci,Elena Sacco,Lucia Centofanti,Massimo Venturini,Serena Mazzucchelli,Deborah Mattinzoli,Masami Ikehata,Giuseppe Castellano,Gary Visner,Liu Kaifeng,Kang Mi Lee,Zhimin Wang,Domenico Corradi,Stefano La Rosa,Silvio Danese,Jun Yang,James F. Markmann,Gian Vincenzo Zuccotti,Reza Abdi,Franco Folli,Paolo Fiorina
DOI: https://doi.org/10.1016/j.cmet.2024.05.001
IF: 29
2024-06-05
Cell Metabolism
Abstract:Here, we show that GLP-1R is expressed by T cells, and its signaling prolongs allograft survival and mitigates alloimmunity. Notably, GLP-1R antagonism triggered anti-tumor immunity in a mouse model of colorectal cancer. GLP-1R acts as a T cell-negative costimulatory molecule.
cell biology,endocrinology & metabolism